News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Epigenomics AG Life Technologies to Supply Crucial Components for Second-Generation Colorectal Cancer Blood Test



5/6/2011 9:21:29 AM

BERLIN & SEATTLE, Wash.--(BUSINESS WIRE)--Epigenomics AG (Frankfurt Prime Standard: ECX), the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions. As the Original Equipment Manufacturer (OEM) Life Technologies will supply its Dynabeads® MyOne™ SILANE and buffers for Epigenomics’ Epi proColon® 2.0 – the company’s second-generation colorectal cancer blood test that is in development for the European and U.S. in vitro diagnostic (IVD) market.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES